On July 6, 2022, the FDA updated the Emergency Use Authorization (EUA) for the COVID-19 antiviral Paxlovid, to permit pharmacists to prescribe Paxlovid under limited circumstances. The FDA hoped to help populations at high risk of hospitalization or...
On July 6, 2022, the Food and Drug Administration (FDA) announced that state-licensed pharmacists are authorized to prescribe the Covid-19 anti-viral medication, Paxlovid, in limited circumstances. Manufactured by Pfizer, Paxlovid decreases the seve...